We are live on ! Find out more
CIS

Capital International Sarl Portfolio holdings

AUM $6.11B
1-Year Est. Return 32.29%
This Fund
S&P 500
This Quarter Est. Return
+14.26%
1 Year Est. Return
+32.29%
3 Year Est. Return
+120.6%
5 Year Est. Return
+165.23%
10 Year Est. Return
+684.77%
AUM
$2.67B
AUM Growth
+$484M
Cap. Flow
+$193M
Cap. Flow %
7.23%
Top 10 Hldgs %
28.33%
Holding
229
New
8
Increased
140
Reduced
50
Closed
7

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$18.6M
2
META icon
Meta Platforms (Facebook)
META
+$13.3M
3
AVGO icon
Broadcom
AVGO
+$9.41M
4
TSLA icon
Tesla
TSLA
+$7.57M
5
CRM icon
Salesforce
CRM
+$7.36M

Top Sells

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$8.99M
2
EW icon
Edwards Lifesciences
EW
+$6.3M
3
SRE icon
Sempra
SRE
+$4.5M
4
CTVA icon
Corteva
CTVA
+$3.85M
5
HES
Hess
HES
+$3.02M

Sector Composition

Rank Sector Weight
1 Technology 26.32%
2 Healthcare 16.49%
3 Consumer Discretionary 13.29%
4 Financials 10.76%
5 Industrials 10.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTRS icon
226
Viatris
VTRS
$18.7B
-33,638
Closed -$332K
CTLT
227
DELISTED
CATALENT, INC.
CTLT
-5,285
Closed -$241K
SGEN
228
DELISTED
Seagen Inc. Common Stock
SGEN
-42,362
Closed -$8.99M

Similar funds

Capital International Sarl's Q4 2023 Portfolio in Review

As of Q4 2023, Capital International Sarl held 229 positions worth $2.67B, up 22% from $2.19B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Capital International Sarl deployed $193M of net new capital in Q4 2023, opening 8 new positions and adding to 140 existing holdings. Its largest new stake was Brookfield: 172,452 shares worth $4.61M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Edwards Lifesciences, an estimated $6.3M trimmed.

  • Capital International Sarl's largest Q4 2023 buy was Brookfield: 172,452 shares worth $4.61M.
  • Capital International Sarl added most to Microsoft in Q4 2023, an estimated $18.6M increase.
  • Capital International Sarl's biggest Q4 2023 reduction was Edwards Lifesciences, cutting an estimated $6.3M.
  • Capital International Sarl fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $8.99M.
  • Capital International Sarl's ten largest holdings make up 28% of its $2.67B portfolio in Q4 2023.
  • Capital International Sarl opened 8 new positions and closed 7 in Q4 2023.
  • Capital International Sarl's portfolio value rose 22% quarter-over-quarter to $2.67B.

Based on Capital International Sarl's 13F filing for Q4 2023, filed 13 Feb 2024.